World Of Taxonomy
C160526Level 5

Bevacizumab/Lomustine Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bevacizumab and lomustine that can be used for the treatment of certain central nervous system (CNS) cancers including oligodendroglioma, astrocytoma, glioblastoma (GBM) and gliosarcoma.

**Synonyms:** - Bevacizumab-Lomustine - Bevacizumab/Lomustine - Lomustine and Bevacizumab - Lomustine and Bevacizumab-adcd - Lomustine and Bevacizumab-awwb - Lomustine and Bevacizumab-aybi - Lomustine and Bevacizumab-bvzr - Lomustine and Bevacizumab-equi - Lomustine and Bevacizumab-maly - Lomustine and Bevacizumab-onbe - Lomustine and Bevacizumab-tnjn - Lomustine-Bevacizumab - Lomustine/Bevacizumab - Lomustine/Bevacizumab Regimen

GET/api/v1/systems/nci_thesaurus/nodes/C160526
Official DownloadCC BY 4.0Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.